Trial intelligence / Profile preview

Duloxetine in MDD with Soft Tissue Discomfort

NCT01035073Phase 4Completed

Sponsor
University of Pennsylvania
Start
Apr 2006
Primary completion
May 2009
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of duloxetine in major depressive disorder (MDD), fibromyalgia (FM), sponsored by University of Pennsylvania. Started Apr 2006; status: completed.

02

Drugs

duloxetine
03

Conditions

major depressive disorder (MDD)fibromyalgia (FM)

Beyond the preview

Go deeper on NCT01035073.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01035073.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call